Pricing Log in Create free account

PepGen, Inc. (PEPG) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

PepGen, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. PepGen, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($169.7M and $166.6M). Across the 9 metrics below, Zentalis Pharmaceuticals, Inc. leads on 5 and PepGen, Inc. on 4.

Valuation

Metric PEPG ZNTL Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 1.34 0.85 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.34 0.65
EV/Sales n/m n/m 8.98
Earnings yield (56.71%) (114.04%) (34.89%)
Free cash flow yield (43.48%) (104.95%) (24.52%)

Profitability

Metric PEPG ZNTL Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (75.45%) (66.75%) (50.12%)
Return on assets (59.06%) (49.22%) (45.60%)
Return on invested capital (2,076.25%) 0.00% 0.00%

Growth

Metric PEPG ZNTL Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 25.61% 18.03% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PEPG ZNTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.36 4.82 4.89
Net debt to EBITDA 1.64 1.59 1.01

Dividend

Metric PEPG ZNTL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PEPG ZNTL Biotechnology median
Market cap 169.69m 166.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack